
From isolation to exploration
During Loneliness Awareness Week, we're hosting a special webinar to address the challenges faced by individuals with sight loss when it comes to travel and mobility.
Search results
During Loneliness Awareness Week, we're hosting a special webinar to address the challenges faced by individuals with sight loss when it comes to travel and mobility.
During Loneliness Awareness Week, we're hosting a special webinar to address the challenges faced by individuals with sight loss when it comes to travel and mobility.
Join us for an inspiring webinar where young adults living with sight loss share their extraordinary stories and insights
Join us for an inspiring webinar where young adults living with sight loss share their extraordinary stories and insights.
A new approach to treating inherited sight loss
Are you supporting someone with inherited sight loss? We are here to help.
Introducing Splice Bio, a genetic medicines company with some exciting developments for Stargardt’s patients.
A deep dive into CBS with Dr Jasleen Jolly
Biotechnology company MeiraGTx has announced encouraging news from its phase 1/2 clinical trial of botaretigene sparoparvovec (previously known as AAV-RPGR), a gene therapy aimed at X-linked retinitis pigmentosa caused by faults in the RPGR gene.
Inside this edition, set yourself a challenge in 2024, plus find out about our brand new lottery.